# IL-6 Regulation of Energy Stores During Recovery From an Acute Exercise Bout

> **NCT05349149** · NA · COMPLETED · sponsor: **Helga Ellingsgaard** · enrollment: 30 (actual)

## Conditions studied

- Glycogen Depletion

## Interventions

- **DRUG:** Tocilizumab/Actemra® (Roche)
- **DRUG:** Saline 9%

## Key facts

- **NCT ID:** NCT05349149
- **Lead sponsor:** Helga Ellingsgaard
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-20
- **Primary completion:** 2022-10-11
- **Final completion:** 2022-10-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05349149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05349149, "IL-6 Regulation of Energy Stores During Recovery From an Acute Exercise Bout". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05349149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*